Interest: A high school senior from New Hampshire with her eyes on Bryant University for her studies next year, Emily Gravel traveled to the school for Startup Weekend.
When she arrived Friday, she thought she’d shadow another participant, but she didn’t plan to launch her own idea for a new business.
Interest: The venture capital industry is facing real competition for the first time in decades. Not only that, but the growing battle between venture capital firms and “super angels” presents an amazing opportunity for entrepreneurs trying to build the next big thing.
Interest: FAU and industry partner Rose Pearl, LLC will capitalize on industry demand for an alternative to the rare natural pearls of the queen conch - a commercially threatened species
Interest: Texas is clearly a leader in the global economy, and critical to maintaining our position of leadership is keeping our intellectual and financial capital – and the jobs for Texans that they create – here at home.
Interest:
Startech and the South Texas Regional Center of Innovation and Commercialization (STRCIC) today announced the investment of $2.5 million in San Antonio-based ViroXis Corporation by the Texas Emerging Technology Fund (TETF). The award is to advance the product development and commercialization of its topical Albuterpenoid drug, a patented anti-viral therapeutic derived from East Indian Sandalwood oil (EISO), aimed at treating common skin warts, a highly prevalent disease that currently lacks a
Interest: The University of Toledo, which already has a reputation in solar panel research, Friday was approved for a $3.5 million grant that could bolster its help to panel manufacturers and boost its expertise in photovoltaics.
Interest: Start-up firm Tasmanian Air Adventures is set to take off at the end of this year after winning $25,000 from an RMIT University business plan competition.
Interest: ALBANY -- The University at Albany's College of Nanoscale Science and Engineering celebrated the groundbreaking of its new research center in the Utica area Thursday and the addition of a new manufacturing partnership in Canandaigua.
Interest: An Idaho-based tech company with a Fresno office has been named one of the most innovative providers of machine-to-machine communication technology.
Interest: The South Side Innovation center received an $85,000 grant from JPMorgan Chase to support entrepreneurial efforts in Syracuse's South Side neighborhood.
Interest: Venture-capital investment fell in the third quarter from last year's levels, an unwelcome reminder of the recovering investment market's tentative nature.
Interest: COLUMBIA — The University of Missouri System Enterprise Investment program, which opened for applications this month, will invest up to $5 million in university-affiliated start-ups.
Interest: Baseball legend Lou Gehrig immortalized himself in 1939 as "the luckiest man on the face of this earth." Over 70 years after Gehrig's heart-breaking speech, however, there's precious little luck for sufferers of the fatal disease often bearing his name. However, a local doctor's drug discovery-- combined with the an entrepreneurial strategy by an up-and-coming office affiliated with the University of Virginia-- may change the outlook for patients with Amyotrophic Lateral Sclerosis.
Interest: Queen's University Innovation Park researcher Dr. Michael Shannon, who is doing research of hospital room decontamination and sterlization shows his equipment to Federal Government House Leader John Baird, right, Leeds-Grenville M.P.Gord Brown after Baird made an announcement at Innovation Park as the federal government announced funding for a partnership between Queen's, St. Lawrence College, small and medium size businesses bring products and new ideas to the marketplace faster. Queen's received $750,000 while St. Lawrence College received $154,993.
Interest:
In early October, HemoSonics, a company in Charlottesville, Virginia which makes blood diagnostic equipment, announced it received three small business research grants from National Institutes of Health and Office of Naval Research. HemoSonics is the kind of company — small, innovative, and based on the home-grown creation of knowledge — that our country depends on to lead the way out of our stalled economy.
Interest: Stratatech Corp., a regenerative medicine company focused on the commercialization of cell-based, tissue-engineered skin substitute products, today announced that the Defense Department’s Armed Forces Institute of Regenerative Medicine AFIRM) will fund the Phase IIb clinical trial of the company’s flagship StrataGraft® living human skin substitute tissue.
Interest: Some of the scientific work going on behind the laboratory walls at the University of Pittsburgh was on display Wednesday night, giving the public and the business community the opportunity to see what sort of commercialization prospects are available.
My profile
Loading...